Drughunter
Portland, US · Founded 2022 · 2 known investors
Drug Hunter publishes educational content, molecule case studies, patent highlights, and analysis on small molecule and biologic drug discovery for medicinal chemists and pharmaceutical R&D professionals. The site covers therapeutic targets, clinical-stage molecules, and drug development strategies across oncology, neurology, and other disease areas.
Founders & leadership
Drughunter was founded in 2022 by Dennis X. Hu.
DX
Dennis X. HuFounder
Board
TL
Investors · 2
Reported raises · per SEC filings
Form D private placements$6.8M disclosed across 3 rounds · 2022–2025
▶$6MraisedSep 2025 · 13 investors · OtherRule 506(b)
▶$6MraisedSep 2025 · 13 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Dennis X. HuExecutive Officer, Director, Promoter
- Thomas LehrmanDirector
- Offering amount
- $7M
- Amount sold
- $6M
- First sale
- Sep 2025
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$50KraisedMar 2024 · 1 investors · OtherRule 506(b)
▶$50KraisedMar 2024 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Dennis HuExecutive Officer, Director, Promoter
- Offering amount
- $2M
- Amount sold
- $50K
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
▶$698.4KraisedJan 2023 · 9 investors · OtherRule 506(b)
▶$698.4KraisedJan 2023 · 9 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Dennis HuExecutive Officer, Director, Promoter
- Offering amount
- $1.5M
- Amount sold
- $698.4K
- Minimum investment
- $10K
- First sale
- Jan 2022
- Incorporated
- Corporation, Delaware, 2022
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Drughunter do?
- Drug Hunter publishes educational content, molecule case studies, patent highlights, and analysis on small molecule and biologic drug discovery for medicinal chemists and pharmaceutical R&D professionals. The site covers therapeutic targets, clinical-stage molecules, and drug development strategies across oncology, neurology, and other disease areas.
- Who founded Drughunter?
- Drughunter was founded by Dennis X. Hu in 2022.
- Who are Drughunter's investors?
- Drughunter's investors include FCA Venture Partners, Teamworthy Ventures.
- How much funding has Drughunter raised?
- Drughunter has disclosed $6.8M raised across 3 rounds.
- Where is Drughunter headquartered?
- Drughunter is headquartered in Portland, US.